Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Brain Sci ; 11(10)2021 Oct 14.
Artigo em Inglês | MEDLINE | ID: mdl-34679413

RESUMO

AIMS: To introduce a resource supporting research on Gulf War illness (GWI) and related disorders, the Gulf War Veterans' Illnesses Biorepository (GWVIB). METHODS: Gulf War era veterans (GWVs) are recruited nationally and enrolled via telephone and email/postal mail. Enrolled veterans receive annual telephone and mail follow-up to collect health data until their passing. A postmortem neuropathological examination is performed, and fixed and frozen brain and spinal cord samples are banked to support research. Investigators studying GWI and related disorders may request tissue and data from the GWVIB. RESULTS: As of September 2021, 127 GWVs from 39 states were enrolled; 60 met the criteria for GWI, and 14 met the criteria for chronic multisymptom illness (CMI). Enrollees have been followed up to six years. Postmortem tissue recoveries were performed on 14 GWVs. The most commonly found neuropathologies included amyotrophic lateral sclerosis, chronic traumatic encephalopathy, and Lewy body disease. Tissue was of good quality with an average RNA integrity number of 5.8 (SD = 1.0) and ≥4.8 in all of the cases. DISCUSSION: The availability of health data and high-quality CNS tissue from this well-characterized GWV cohort will support research on GWI and related disorders affecting GWVs. Enrollment is ongoing.

2.
Endocr Pract ; 18(5): e111-3, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22440982

RESUMO

OBJECTIVE: To report a case of erlotinib-associated exacerbation of hypothyroidism complicated by pericardial tamponade. METHODS: We describe the patient's clinical presentation, biochemical workup, and clinical course. RESULTS: Non-small cell lung cancer was diagnosed in a 54-year-old woman. After cisplatin and radiation therapy, she was noted to have subclinical hypothyroidism that did not necessitate treatment. The tyrosine kinase inhibitor erlotinib, 150 mg once daily, was prescribed. Three months later, the patient was documented to have severe hypothyroidism. Levothyroxine was prescribed, but she continued to experience shortness of breath, fatigue, and chest and back pain, which resulted in an emergency department visit. Inpatient workup revealed cardiac tamponade with a large pericardial effusion and a right ventricular diastolic collapse. Pericardiocentesis was performed. CONCLUSIONS: This is the first case report linking erlotinib use and thyroid disease.


Assuntos
Tamponamento Cardíaco/induzido quimicamente , Hipotireoidismo/induzido quimicamente , Quinazolinas/efeitos adversos , Tamponamento Cardíaco/tratamento farmacológico , Tamponamento Cardíaco/terapia , Cloridrato de Erlotinib , Feminino , Humanos , Pessoa de Meia-Idade , Quinazolinas/uso terapêutico , Tiroxina/uso terapêutico
4.
Curr Hypertens Rep ; 9(6): 512-9, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18367016

RESUMO

The many similarities between the metabolic syndrome and Cushing's syndrome led to the hypothesis that excess glucocorticoids (GC) are part of the pathogenesis linking their features. We review recent work that confirms the initial similarities (obesity, glucose intolerance, hypertension, and hyperlipidemia) and extends them to associated features of both syndromes (osteopenia, hypogonadism, leukocytosis, depression, and muscle weakness). Recent studies report that these features also occur in subclinical Cushing's syndrome, hypercortisolemic depression, and the transgenic overexpression of 11beta-hydoxysteroid dehydrogenase type 1 (11beta-HSD1) in mouse models of excess GC in adipose tissue. Reducing excess GC--in the clinical syndromes and in the mouse model-reverses many of these features. Because local tissue excess GC may have a central role in the pathogenesis of the metabolic syndrome, selective 11beta-HSD1 inhibitors are under active development by several pharmaceutical companies.


Assuntos
Corticosteroides/sangue , Glândulas Suprarrenais/patologia , Síndrome de Cushing/fisiopatologia , Síndrome Metabólica/fisiopatologia , Esteroides/sangue , Aldosterona/sangue , Doenças Ósseas Metabólicas/fisiopatologia , Endotélio/fisiopatologia , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...